Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasios Lymperopoulos

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Frontiers in Bioscience (Landmark Edition)|January 8, 2026
Why Is Epinephrine Preferred for Cardiac Arrest? The Answer May Lie in β<sub>2</sub>-Adrenergic Receptor ActivationAnastasios Lymperopoulos, Alexis J M'Sadoques, Renee A Stoicovy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 29, 2008
Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activityAnastasios Lymperopoulos, Giuseppe Rengo, Carmela Zincarelli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 26, 2016
Hypothesis: Paroxetine, a G Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor Reduces Morbidity and Mortality in Patients With Heart FailureJonathan M Powell, Emanuel Ebin, Steven Borzak, et al.
The FEBS Journal|February 18, 2021
Signaling and function of cardiac autonomic nervous system receptors: Insights from the GPCR signalling universeAnastasios Lymperopoulos, Natalie Cora, Jennifer Maning, et al.
Nature Medicine|February 27, 2007
Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failureAnastasios Lymperopoulos, Giuseppe Rengo, Hajime Funakoshi, et al.
International Journal of Molecular Sciences|October 14, 2022
Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment ContractilityJennifer Maning, Victoria L Desimine, Celina M Pollard, et al.
Therapeutic Advances in Cardiovascular Disease|August 13, 2019
The place of ARBs in heart failure therapy: is aldosterone suppression the key?Uma Markan, Samhitha Pasupuleti, Celina M Pollard, et al.
Current Issues in Molecular Biology|December 22, 2022
Autonomic Nervous System Regulation of Epicardial Adipose Tissue: Potential Roles for Regulator of G Protein Signaling-4Alexandra M Carbone, Giselle Del Calvo, Deepika Nagliya, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2022
GTPγS Assay for Measuring Agonist-Induced Desensitization of Two Human Polymorphic Alpha<sub>2B</sub>-Adrenoceptor VariantsJordana I Borges, Alexandra M Carbone, Natalie Cora, et al.
Pharmacological Research|October 18, 2021
Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signalingAnastasios Lymperopoulos, Jordana I Borges, Alexandra M Carbone, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Frontiers in Bioscience (Landmark Edition)|January 8, 2026
Why Is Epinephrine Preferred for Cardiac Arrest? The Answer May Lie in β<sub>2</sub>-Adrenergic Receptor ActivationAnastasios Lymperopoulos, Alexis J M'Sadoques, Renee A Stoicovy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 29, 2008
Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activityAnastasios Lymperopoulos, Giuseppe Rengo, Carmela Zincarelli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 26, 2016
Hypothesis: Paroxetine, a G Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor Reduces Morbidity and Mortality in Patients With Heart FailureJonathan M Powell, Emanuel Ebin, Steven Borzak, et al.
The FEBS Journal|February 18, 2021
Signaling and function of cardiac autonomic nervous system receptors: Insights from the GPCR signalling universeAnastasios Lymperopoulos, Natalie Cora, Jennifer Maning, et al.
Nature Medicine|February 27, 2007
Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failureAnastasios Lymperopoulos, Giuseppe Rengo, Hajime Funakoshi, et al.
International Journal of Molecular Sciences|October 14, 2022
Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment ContractilityJennifer Maning, Victoria L Desimine, Celina M Pollard, et al.
Therapeutic Advances in Cardiovascular Disease|August 13, 2019
The place of ARBs in heart failure therapy: is aldosterone suppression the key?Uma Markan, Samhitha Pasupuleti, Celina M Pollard, et al.
Current Issues in Molecular Biology|December 22, 2022
Autonomic Nervous System Regulation of Epicardial Adipose Tissue: Potential Roles for Regulator of G Protein Signaling-4Alexandra M Carbone, Giselle Del Calvo, Deepika Nagliya, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2022
GTPγS Assay for Measuring Agonist-Induced Desensitization of Two Human Polymorphic Alpha<sub>2B</sub>-Adrenoceptor VariantsJordana I Borges, Alexandra M Carbone, Natalie Cora, et al.
Pharmacological Research|October 18, 2021
Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signalingAnastasios Lymperopoulos, Jordana I Borges, Alexandra M Carbone, et al.
Pageof 11